2,456 material Form 8-K filings that 2,073 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
TKO Group Holdings priced a $1.0 billion offering of 6.500% Senior Secured Notes due 2031, issued by its indirect subsidiary TKO Worldwide Holdings, LLC. The company said net proceeds may fund general corporate purposes, including distributions to parent entities to fund share repurchases under its existing program. The offering adds $1.0 billion of secured debt, which shareholders may weigh against the planned buybacks.
Pricing announced November 5, 2026: $1.0 billion aggregate principal amount of 6.500% Senior Secured Notes due 2031
Issuer is indirect subsidiary TKO Worldwide Holdings, LLC; notes guaranteed by TKO Guarantor, LLC and certain subsidiaries
Proceeds may fund share repurchases under TKO's previously announced program, plus fees and expenses
Closing expected on or about November 13, 2026, subject to customary conditions
Parabolic Technologies, Inc. (Nasdaq: PARA) closed a $13.5 million underwritten public offering on November 5, 2026, selling units that each include one share or a pre-funded warrant plus two warrants. The filing says net proceeds were approximately $5.512 million, and the warrants include exercise-price resets that can increase the number of shares issuable, which could dilute existing shareholders.
Gross proceeds of about $13.5 million from 4,963,235 units priced at $2.72 each, with net proceeds of about $5.512 million after offering expenses
Each unit includes two warrants with an initial exercise price of $6.80 per share, for up to 9,926,470 warrant shares
Warrants reset on the fifth and tenth trading days after issuance to the lower of the then-current exercise price and 80% of the lowest VWAP in the measurement period, subject to floor prices, and holders keep additional shares from resets
Aegis Capital Corp. holds a 45-day over-allotment option, and the Underwriter exercised it for 360,000 warrants on November 5, 2026
Annovis Bio agreed on November 5, 2026 to sell 19,000,000 shares of common stock (or pre-funded warrants in lieu of shares) with accompanying warrants, with expected gross proceeds of approximately $21.0 million before underwriting discounts and expenses. The offering adds shares and warrants that could dilute existing shareholders, while the company plans to use the proceeds for clinical development of buntanetap and working capital.
Offering of 19,000,000 shares plus pre-funded warrants for up to 2,000,000 shares, with accompanying warrants for up to 21,000,000 shares, priced at $1.00 per share and accompanying warrant
Accompanying warrants are exercisable at $1.00 per share and expire five years after issuance
One of the company's directors is buying 5,000,000 shares and accompanying warrants for $5,000,000
Offering is expected to close on or about November 6, 2026, with Canaccord Genuity LLC as underwriter
On November 2, 2026, Public Policy Holding Company, Inc. (PPHC) entered a $105 million senior secured credit facility with Bank of America, N.A. as administrative agent, and used it to repay and terminate its existing credit agreement. The facility consists of a $65 million term loan and a $40 million revolving credit facility, maturing November 2, 2031, and the company says proceeds will also fund the Reevemark acquisition and working capital.
Facility of $105 million: a $65 million term loan and a $40 million revolving credit facility, maturing November 2, 2031
$65 million was borrowed under the term loan at closing
Interest is SOFR plus 185 to 230 basis points, set by net leverage; the company plans syndication to $150 million, expected to close January 2027 on a best-efforts basis
Existing credit agreement dated February 28, 2023 was repaid and terminated
CBRE Services, a wholly-owned subsidiary of CBRE Group, completed a $1 billion offering of senior notes in two $500 million tranches due 2032 and 2037. The Company intends to use the proceeds for general corporate purposes, including repaying commercial paper borrowings and funding the pending acquisition of Onnec Group Limited, which adds debt that shareholders will need to service.
$500 million of 5.650% Senior Notes due January 15, 2032, with semi-annual interest beginning January 15, 2027
$500 million of 5.900% Senior Notes due January 15, 2037, with semi-annual interest beginning January 15, 2027
Notes are fully and unconditionally guaranteed on a senior unsecured basis by CBRE Group, Inc.
Proceeds intended for commercial paper repayment and the pending acquisition of Onnec Group Limited
Meta Platforms completed a $15.0 billion offering of five U.S. dollar senior note series maturing from 2031 to 2056, with fixed rates from 5.850% to 7.500%. Underwriters also exercised in full their option to buy 6,000,000 additional Class A common shares from an offering priced in late October 2026, with forward sale agreements covering those shares. The filing does not state how the proceeds will be used, so the added debt and share sales are the main points for shareholders to weigh.
Five senior note series: $3.25 billion due 2031, $3.25 billion due 2033, $4.0 billion due 2036, $1.75 billion due 2046 and $2.75 billion due 2056
Notes were issued under an indenture dated August 9, 2022 with U.S. Bank Trust Company, National Association, as trustee, and a sixth supplemental indenture dated November 5, 2026
Underwriters exercised their option in full on November 4, 2026 for 6,000,000 additional Class A common shares, with additional forward sale agreements on similar terms
Underwriting agreement dated November 3, 2026 with Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC as representatives
CVR Energy agreed to sell 10,515,248 common shares at $47.55 each, with net proceeds of about $490.0 million before offering expenses, closing November 5, 2026. The company plans to use the proceeds with cash on hand and other financing to fund its acquisition of the St. Paul Park and Mandan refineries from Marathon Petroleum subsidiaries, redeem its 5.750% Senior Notes due 2028, and pay related fees.
Offering: 10,515,248 shares at $47.55 per share, with a 30-day option for up to 1,577,287 additional shares
Net proceeds of approximately $490.0 million; offering closed November 5, 2026
Proceeds to fund the St. Paul Park and Mandan refinery acquisition and redeem 2028 Notes; if the acquisition does not close, proceeds go to general corporate purposes
Selling stockholder IEP Energy Holding LLC is not included in the priced offering; the company receives no proceeds from its shares
Otis Worldwide issued $500 million of 5.825% notes maturing November 5, 2036, with estimated net proceeds of about $495.3 million. The company plans to use the proceeds with cash on hand to repay its 2.293% notes due April 5, 2027, which had $500 million outstanding as of September 30, 2026. This is a routine debt refinancing that replaces near-term maturing debt with longer-dated debt at a higher stated interest rate.
Notes: $500 million principal, 5.825% annual interest, maturing November 5, 2036; interest payable May 5 and November 5 starting May 5, 2027
Estimated net proceeds of about $495.3 million, to repay 2.293% notes due April 5, 2027 ($500 million outstanding at September 30, 2026)
Notes are unsecured and rank equally with existing unsecured debt; make-whole redemption before August 5, 2036; 101% change of control put
Spruce Power subsidiaries amended their KeyBank credit agreement on October 30, 2026, changing covenant terms tied to a refinancing and requiring new deliverables by November 9, 2026. The same day, subsidiaries signed a non-binding term sheet with a financial institution for a funded debt facility to refinance the SP1, SP2 and SP3 facilities, but the filing states the terms remain indicative and subject to change. The filing also warns that failure to complete a refinancing by January 30, 2027 could have serious consequences, including going-concern risk.
October 30, 2026: subsidiaries amended the Second KeyBank Credit Agreement and entered a term sheet with a financial institution
By November 9, 2026: company must deliver a long-term financial model assuming refinancing of Senior Loan Obligations, and SP4 HoldCo and SP5 HoldCo must execute agreements for the SP4/SP5 Collateral Addition covenant
The proposed Refinancing Facility would refinance the SP1, SP2 and SP3 facilities; the filing cites a January 30, 2027 refinancing risk date
Xometry issued a notice to redeem all approximately $85.0 million of its 1.00% Convertible Senior Notes due 2027, with redemption set for November 20, 2026, at 100% of principal plus accrued interest. Holders may still convert the notes into Class A common stock until 5:00 p.m. New York City time on November 19, 2026, and the filing says conversions after the notice will settle in physical shares. The filing is a debt-management step and gives no results or guidance figures.
Notes to be redeemed: all approximately $85.0 million aggregate principal of 1.00% Convertible Senior Notes due 2027
Redemption date: November 20, 2026, at 100% of principal plus accrued and unpaid interest from August 1, 2026
Conversion deadline: 5:00 p.m. New York City time on November 19, 2026; each $1,000 converts into 17.8213 shares, plus 0.0018 additional shares for conversions before the deadline
Live Oak Bancshares agreed on November 4, 2026 to sell 4,000,000 depositary shares, each representing a 1/40th interest in its 8.750% Series B non-cumulative perpetual preferred stock, at a $25 liquidation value per depositary share. The company expects the offering to close on or about November 12, 2026, and says the net proceeds will fund general corporate purposes, including balance sheet growth at Live Oak Banking Company and its capital position.
Underwriters are Morgan Stanley & Co. LLC, Keefe, Bruyette & Woods, RBC Capital Markets and UBS; the underwriters have a 30-day option for up to 600,000 additional depositary shares.
Dividends are 8.750% per annum, payable quarterly when declared by the board, beginning December 15, 2026.
The company may redeem the Series B preferred stock on or after December 15, 2031, or after a regulatory capital treatment event, at $1,000 per share ($25 per depositary share).
Live Oak intends to list the depositary shares on the NYSE under the symbol LOB/PB.
Xcel Energy issued $2.5 billion of 2.625% convertible senior notes due December 15, 2027, including $300 million from the initial purchasers' option. The notes are convertible into Xcel common stock at an initial conversion price of about $87.26 per share, and conversions can be settled in cash, shares, or a mix. Because the notes are convertible, they could add up to 31,513,750 shares of common stock to the share count if holders convert at the maximum rate.
Issued $2,500,000,000 of 2.625% Convertible Senior Notes due December 15, 2027, dated November 5, 2026
Initial conversion rate of 11.4596 shares per $1,000 principal, or about $87.26 per share
Up to 31,513,750 shares may be issued on conversion at the initial maximum conversion rate of 12.6055 shares per $1,000
Notes cannot be redeemed by Xcel Energy before maturity and carry no sinking fund
Enova International priced a private offering of $600 million in senior notes due 2031 at par, bearing 8.750% annual interest, with closing expected November 20, 2026. The company plans to use the proceeds to redeem all of its 11.25% senior notes due 2028 on December 15, 2026, pay offering fees, and repay part of its revolving credit facility borrowings, which refinances higher-rate debt for shareholders to watch.
Offering size: $600 million aggregate principal amount of senior notes due 2031, priced at 100.000% of principal
Interest rate: 8.750% per annum; notes are senior unsecured and guaranteed by domestic subsidiaries
Expected closing: November 20, 2026, subject to customary conditions
Use of proceeds: redeem all 11.25% senior notes due 2028 on December 15, 2026, and repay part of revolver borrowings
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed on November 5, 2026 a public offering of $6.5 billion of senior unsecured notes in seven series maturing from 2028 to 2056, fully guaranteed by HCA Healthcare. The filing does not state how the proceeds will be used, but the offering adds $6.5 billion of debt obligations for the company.
Seven series totaling $6.5 billion; the largest is $1.5 billion of 6.000% senior notes due November 15, 2036.
Fixed-rate coupons range from 5.200% to 6.500%, and $300 million of floating-rate notes mature November 3, 2028.
Underwriting agreement dated November 2, 2026 with Mizuho Securities USA LLC, Barclays Capital Inc., BofA Securities, Inc. and Wells Fargo Securities, LLC as representatives.
Holders can require repurchase at 101% of principal only upon both a qualifying ratings downgrade and a change of control.
TD SYNNEX entered into a $1,750 million senior unsecured term loan with Bank of America as administrative agent, dated November 2, 2026. Part of the proceeds repaid in full an existing $750 million term loan that would have matured September 1, 2027, and the rest will fund general corporate purposes, including acquisitions.
New term loan: $1,750 million, maturing November 2, 2029, with no scheduled amortization before maturity
Interest set at SOFR plus a margin of 1.00% to 1.625%, based on TD SYNNEX's public debt rating
Repaid in full the $750 million term loan that would have matured September 1, 2027
Financial covenants require a maximum funded debt to EBITDA ratio of 4.00 to 1.00 and a minimum EBITDA to interest charges ratio of 3.00 to 1.00
Aeries Technology disclosed a settlement agreement dated October 30, 2026, with Sea Otter Trading, LLC over obligations under a forward purchase agreement. The company agreed to pay $911,461 through an escrow arrangement in exchange for the return of 145,183 Class A ordinary shares held as collateral, and mutual general releases will take effect once the share transfer and payment are completed. The filing does not disclose the company's financial results, and it replaces the earlier letter agreement terms that had been disclosed August 3, 2026.
Settlement agreement dated October 30, 2026, with Sea Otter Trading, LLC
Company to pay $911,461 through escrow to recover 145,183 collateral Class A ordinary shares
Mutual general releases and termination of the Letter Agreement take effect upon completion of the share transfer and payment
Fate Therapeutics entered a Sales Agreement with Leerink Partners for an at-the-market program allowing it to sell up to $100 million of common stock at its discretion, and terminated its earlier $100 million program with Jefferies. The company has already sold 2,801,602 shares for $8.0 million under the Jefferies program. The new program could add shares outstanding and dilute existing shareholders if the company chooses to sell.
Leerink Partners may sell up to $100,000,000 of common stock; the company pays a commission of up to 3.0% of gross proceeds.
The Jefferies program was terminated on November 5, 2026, with no termination penalties, after sales of 2,801,602 shares for $8.0 million.
The existing Form S-3 expires November 27, 2026; the company plans to file a new registration statement, and may sell under the existing one until the earlier of the new registration's effectiveness and May 26, 2027.
Alphabet closed an underwritten public offering of €6 billion in euro-denominated senior notes on November 5, 2026, issued under an indenture dated February 12, 2016. The notes come in seven tranches maturing between 2028 and 2045, which adds to the company's long-term debt.
Total offering of €6 billion across seven tranches, maturing 2028 to 2045
Largest tranches are €1.25 billion of 4.050% notes due 2030 and €1 billion of 5.250% notes due 2045
Issued under a registration statement on Form S-3 and an indenture with The Bank of New York Mellon Trust Company, N.A., as trustee
Brixmor's operating partnership signed a $400 million delayed-draw term loan facility, undrawn as of November 5, 2026, and amended its existing revolving credit and term loan agreements to lower borrowing rates and facility fees. The filing describes financing terms rather than a reported change in earnings, and the facility is not yet drawn.
$400 million delayed-draw term loan facility with Wells Fargo, drawable within six months and maturing February 15, 2031
Revolver amendment with JPMorgan Chase lowers term SOFR margins to 0.65% to 1.35% and facility fees to 0.10% to 0.30%
Term loan amendment lowers term SOFR margins to 0.70% to 1.55%, with pricing tied to credit rating
Aimei Health Technology Co., Ltd. deposited $34,330.96 into its trust account to extend the deadline to complete its initial business combination by one month, from November 6, 2026 to December 6, 2026. The company funded the payment with an unsecured, non-interest-bearing promissory note to Aimei Investment Ltd, which becomes due only at the business combination, so the extension adds to the company's obligations for public shareholders.
Extension Payment of $34,330.96 is the lesser of $80,000 or $0.033 per outstanding public share for each monthly extension.
Termination date moves from November 6, 2026 to December 6, 2026; the filing describes this as the twenty-fourth extension.
Promissory note dated November 5, 2026, issued to Aimei Investment Ltd, is convertible at the payee's option into private units at $10.00 per unit.
On October 29, 2026, Cycurion entered into agreements giving Obsidian Associates, LLC and M2B Funding Corp. a limited right to exchange their Series H Convertible Preferred Stock, plus accrued and unpaid dividends, for common stock at $2.70 per share, subject to a possible Nasdaq Minimum Price adjustment. Upon exchange, the preferred shares are cancelled and the holders receive only common stockholder rights on the new shares, so existing common shareholders may face dilution, though the filing does not state the number of common shares to be issued.
Holders: Obsidian Associates, LLC (618.75 Series H shares) and M2B Funding Corp. (952.70 Series H shares), plus accrued dividends
Exchange price of $2.70 per common share, subject to adjustment to the Nasdaq Minimum Price if applicable
Exchange window opens after the Company files a Listing of Additional Shares notice with Nasdaq and publicly discloses the transactions
Agreements include a 4.99% beneficial ownership limit and a resale limit of 5.0% of average daily trading volume over the prior ten trading days
Prospect Capital Corporation closed a $300 million offering of 8.95% senior unsecured notes due October 31, 2031 on November 5, 2026, issued under a registered direct offering. The Company expects net proceeds of about $283.4 million, mainly to refinance existing debt, including repaying its 3.364% Notes due 2026 and/or revolver borrowings.
Principal: $300 million of 8.95% Notes due October 31, 2031, with interest paid semi-annually on April 30 and October 31, starting April 30, 2027
Expected net proceeds: approximately $283.4 million after estimated offering expenses
Use of proceeds: primarily refinancing, including repayment of the 3.364% Notes due 2026 and/or revolving credit facility borrowings
Optional redemption at par plus a make-whole premium before April 30, 2029; holders may require repurchase at par plus accrued interest upon a Change of Control Repurchase Event
L3Harris closed the sale of $1.0 billion of senior notes on November 5, 2026, split into $500 million due 2029 at 5.200% and $500 million due 2032 at 5.400%. The company plans to use the proceeds for general corporate purposes, including repaying $550 million of 3.85% notes due December 15, 2026 and helping fund part of the $1,250 million 5.40% notes due January 15, 2027.
$1.0 billion total: $500 million of 5.200% notes due 2029 and $500 million of 5.400% notes due 2032
Proceeds earmarked for the $550 million 3.85% notes maturing December 15, 2026
Proceeds, with cash on hand, to partly fund the $1,250 million 5.40% notes maturing January 15, 2027
Kartoon Studios said its sponsored subsidiary, Kartoon Studios Acquisition Corp. (KSAC), filed a Form S-1 registration statement for a proposed $300 million initial public offering of units. The registration statement has not yet become effective, and the units cannot be sold until it does. KSAC intends to pursue media and entertainment business combinations, and the company said there is no assurance the filing will result in any transaction.
Proposed offering of 30,000,000 units at $10.00 per unit, for gross proceeds of $300.0 million, plus an underwriter option for up to an additional 15% of units
Each unit consists of one Class A ordinary share and one redeemable warrant; KSAC intends to list the units on the New York Stock Exchange under the symbol 'KACQ U'
E.F. Hutton & Co. is sole underwriter and book-running manager; Kartoon owns 100% of the sponsor, Toon Acquisition LLC
Andy Heyward, Brian Parisi and Michael Jaffa will lead KSAC, and the filing was announced on November 5, 2026
HCW Biologics entered into a notes purchase agreement with Streeterville Capital on November 3, 2026, and closed the financing on November 4, 2026. The company received $3.0 million at closing, with a further $7.0 million held in a controlled account subject to conditions, and says it will use the proceeds for clinical development, business development and general corporate purposes. The notes are secured and carry lender redemption rights, default triggers and a 10% prepayment premium, which shareholders should weigh against the added funding.
$3.0 million received at closing on November 4, 2026, after $30,000 in transaction costs; a further $7.0 million is deposited in a controlled account subject to conditions
Promissory Note A-1 of $3.2 million includes a $240,000 original issue discount; Note B of $7.0 million carries no discount; both are due in 24 months, at 8% and 5% interest per annum
Beginning six months after closing, the lender may redeem up to $125,000 per calendar month on the A-1 Note; the notes are secured by a controlled account, a subsidiary guaranty and a pledge of subsidiary membership interests
Maxim Group LLC, the placement agent, is to receive a cash fee of 7.0% of gross proceeds
Avalo Therapeutics entered an at-the-market sales agreement with Jefferies LLC that lets it sell up to $200 million of common stock over time at its discretion, with a commission of up to 3.0% of gross proceeds. The same day, the company ended its prior at-the-market agreement with TD Cowen, effective immediately, so new share sales can only occur under the Jefferies arrangement. New share sales would add to the outstanding shares and could dilute existing shareholders.
Jefferies sales agreement covers up to $200,000,000 in aggregate offering price under a prospectus supplement dated November 5, 2026.
Company pays Jefferies a commission of up to 3.0% of gross proceeds from any shares sold.
The company is not obligated to sell any shares, and it may suspend or terminate the offering.
TD Cowen sales agreement, dated June 5, 2025, was terminated effective November 5, 2026.
America's Car-Mart amended its Credit and Guaranty Agreement with Silver Point Finance, LLC, as agent, and its lenders, and agreed to further extend the Scheduled Termination Date and temporary relief on minimum liquidity and Collateral Coverage Ratio requirements through November 9, 2026. The filing shows the company needed repeated short extensions of its credit terms, which signals ongoing pressure on its lending arrangements for shareholders.
First Amendment and Limited Waiver to the Credit Agreement dated October 30, 2025, with Silver Point Finance, LLC as Administrative Agent and Collateral Agent
Scheduled Termination Date previously extended through November 4, 2026, and now extended again through November 9, 2026
Temporary relief on minimum liquidity thresholds and minimum Collateral Coverage Ratio also extended through November 9, 2026
3D Systems signed a Controlled Equity Offering sales agreement with Cantor Fitzgerald & Co. allowing it to sell common stock worth up to $42.5 million through an at-the-market program, at its discretion. The filing states the company is not obligated to sell any shares, so sales would dilute existing holders only if and when they occur.
Agreement dated November 5, 2026 covers shares with an aggregate offering price of up to $42,500,000
Cantor Fitzgerald will be paid a commission of up to 3.0% of the gross sales price per share sold
Shares will be issued under a Form S-3 shelf registration declared effective May 27, 2026
Either the company or Cantor Fitzgerald may terminate the agreement on ten business days' written notice
Dream Finders Homes said that as of 5:00 p.m. New York City time on November 4, 2026, holders had tendered 99.22% of Beazer's 7.500% notes due 2031 and 98.28% of its 8.000% notes due 2032 in an exchange for new Dream Finders notes, and it received the majority consents needed to amend the Beazer indentures. The amendments would eliminate substantially all restrictive covenants and events of default, and would bind all holders of each series once operative. The exchange offer expires November 20, 2026, with settlement expected November 23, 2026, and the filing does not include any financial results.
7.500% notes due 2031: $248,062,000 of $250,000,000 principal tendered (about 99.22%) as of November 4, 2026.
8.000% notes due 2032: $393,125,000 of $400,000,000 principal tendered (about 98.28%) as of November 4, 2026.
Early participants receive $1,000 of new Dream Finders notes, a $50 early participation premium and $1.00 in cash per $1,000 exchanged; later tenders receive $950 of new notes per $1,000.
Expiration is 5:00 p.m. New York City time on November 20, 2026; settlement is expected November 23, 2026.
3D Systems agreed on November 4, 2026 to exchange all $92,030,000 of its 5.875% convertible senior secured notes due 2030 for $85,000,000 of new 3.30% convertible notes due 2031, 13,471,138 common shares and $20,000,000 in cash. The company says the exchange would eliminate all secured debt, and it expects to close on or about November 12, 2026, subject to conditions. Shareholders face potential dilution from the new shares and the up to 32,196,963 shares that could be issued on conversion, and the company receives no cash proceeds from the exchange.
Exchange covers all $92,030,000 of 2030 Notes; holders receive $85,000,000 of 3.30% notes due April 1, 2031, 13,471,138 shares and $20,000,000 in cash
New notes carry an initial conversion price of about $3.43, a premium of about 30.0% over the $2.64 closing price on November 4, 2026
Closing expected on or about November 12, 2026; closing may be postponed to November 19 or December 4, 2026, and the agreements terminate if closing has not occurred by December 15, 2026
The company will not receive any cash proceeds from the exchange
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.